335 related articles for article (PubMed ID: 23303049)
1. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
Edison P; Ahmed I; Fan Z; Hinz R; Gelosa G; Ray Chaudhuri K; Walker Z; Turkheimer FE; Brooks DJ
Neuropsychopharmacology; 2013 May; 38(6):938-49. PubMed ID: 23303049
[TBL] [Abstract][Full Text] [Related]
2. Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
Fan Z; Aman Y; Ahmed I; Chetelat G; Landeau B; Ray Chaudhuri K; Brooks DJ; Edison P
Alzheimers Dement; 2015 Jun; 11(6):608-21.e7. PubMed ID: 25239737
[TBL] [Abstract][Full Text] [Related]
3. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
Edison P; Rowe CC; Rinne JO; Ng S; Ahmed I; Kemppainen N; Villemagne VL; O'Keefe G; Någren K; Chaudhury KR; Masters CL; Brooks DJ
J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1331-8. PubMed ID: 18653550
[TBL] [Abstract][Full Text] [Related]
4. Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
Femminella GD; Ninan S; Atkinson R; Fan Z; Brooks DJ; Edison P
J Alzheimers Dis; 2016; 51(4):1275-89. PubMed ID: 27060942
[TBL] [Abstract][Full Text] [Related]
5. [Cerebral glucose metabolism in Parkinson's disease with dementia].
Ma AJ; Zhang BS; Pan XD; Gao S; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2623-8. PubMed ID: 19080710
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
Fan Z; Okello AA; Brooks DJ; Edison P
Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
[TBL] [Abstract][Full Text] [Related]
7. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
Bohnen NI; Koeppe RA; Minoshima S; Giordani B; Albin RL; Frey KA; Kuhl DE
J Nucl Med; 2011 Jun; 52(6):848-55. PubMed ID: 21571793
[TBL] [Abstract][Full Text] [Related]
8. [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
Jokinen P; Scheinin N; Aalto S; Någren K; Savisto N; Parkkola R; Rokka J; Haaparanta M; Röyttä M; Rinne JO
Parkinsonism Relat Disord; 2010 Dec; 16(10):666-70. PubMed ID: 20870446
[TBL] [Abstract][Full Text] [Related]
9. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
[TBL] [Abstract][Full Text] [Related]
10. Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study.
Palermo G; Tommasini L; Aghakhanyan G; Frosini D; Giuntini M; Tognoni G; Bonuccelli U; Volterrani D; Ceravolo R
J Alzheimers Dis; 2019; 70(2):597-609. PubMed ID: 31256138
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation and protein pathology in Parkinson's disease dementia.
Kouli A; Camacho M; Allinson K; Williams-Gray CH
Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
[TBL] [Abstract][Full Text] [Related]
12. Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography.
Brooks DJ
Mov Disord; 2009; 24 Suppl 2():S742-7. PubMed ID: 19877240
[TBL] [Abstract][Full Text] [Related]
13. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.
Edison P; Archer HA; Gerhard A; Hinz R; Pavese N; Turkheimer FE; Hammers A; Tai YF; Fox N; Kennedy A; Rossor M; Brooks DJ
Neurobiol Dis; 2008 Dec; 32(3):412-9. PubMed ID: 18786637
[TBL] [Abstract][Full Text] [Related]
14. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
[TBL] [Abstract][Full Text] [Related]
15. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease.
Yokokura M; Mori N; Yagi S; Yoshikawa E; Kikuchi M; Yoshihara Y; Wakuda T; Sugihara G; Takebayashi K; Suda S; Iwata Y; Ueki T; Tsuchiya KJ; Suzuki K; Nakamura K; Ouchi Y
Eur J Nucl Med Mol Imaging; 2011 Feb; 38(2):343-51. PubMed ID: 20844871
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
Yong SW; Yoon JK; An YS; Lee PH
Eur J Neurol; 2007 Dec; 14(12):1357-62. PubMed ID: 17941855
[TBL] [Abstract][Full Text] [Related]
17. Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study.
Terada T; Yokokura M; Yoshikawa E; Futatsubashi M; Kono S; Konishi T; Miyajima H; Hashizume T; Ouchi Y
Ann Nucl Med; 2016 Oct; 30(8):579-87. PubMed ID: 27299437
[TBL] [Abstract][Full Text] [Related]
18. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH
Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071
[TBL] [Abstract][Full Text] [Related]
19. Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.
Petrou M; Dwamena BA; Foerster BR; MacEachern MP; Bohnen NI; Müller ML; Albin RL; Frey KA
Mov Disord; 2015 Jun; 30(7):928-35. PubMed ID: 25879534
[TBL] [Abstract][Full Text] [Related]
20. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.
Okello A; Edison P; Archer HA; Turkheimer FE; Kennedy J; Bullock R; Walker Z; Kennedy A; Fox N; Rossor M; Brooks DJ
Neurology; 2009 Jan; 72(1):56-62. PubMed ID: 19122031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
